Searching for type 2 diabetes genes: Prospects in pharmacotherapy

Pharmacogenomics Journal

Volumn 2, Issue 1, 2002, Pages 25-29

  Sesti, G ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; CALPAIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ARTICLE; CHROMOSOME 15; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG DESIGN; DRUG TARGETING; GENE IDENTIFICATION; GENE LOCUS; GENETIC SCREENING; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; MATURITY ONSET DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; THERMOGENESIS;

ADIPOCYTES; ANIMALS; BODY TEMPERATURE REGULATION; CALPAIN; CHROMOSOME MAPPING; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ISLETS OF LANGERHANS; LINKAGE (GENETICS); MICE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 0036373455     PISSN: 1470269X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.tpj.6500078     Document Type: Article

References (46)

1. Searching for type 2 diabetes genes in the post genome era
2. Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young
3. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus
4. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young
5. Early-onset-type-II diabetes mellitus (MODY4) linked to IPF1
6. Mutation in hepatocyte nuclear factor-1β gene (TCF2) associated with MODY
7. Mutations in NEURODI are associated with the development of type 2 diabetes mellitus
8. Mutations in the insulin receptor gene
9. A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
10. The common PPARγ Prol12Ala polymorphism is associated with decreased risk of type 2 diabetes
11. PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance
12. The mechanisms by which both heterozygous PPAR-gamma deficiency and PPARgamma agonist improve insulin resistance
13. Inhibition of RXR and PPARγ ameliorates diet-induced obesity and type 2 diabetes
14. A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin singaling
15. 972->Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic β-cells
16. 972 amino acid polymorphism in IRS-1 affects glucose metabolism in skeletal muscle cells
17. The Gly972Arg polymorphism in the insulin receptor substrate-1 gene contributes to the variation in insulin secretion in normal glucose-tolerant humans
18. 972 polymorphism in insulin receptor substrate-1 causes apoptosis of human pancreatic islets
19. Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians
20. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene
21. Searching for genetic determinants in the new millennium
22. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, β cell dysfunction, and type 2 diebetes
23. A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans
24. Physiological levels of mammalian uncoupling protein 2 do not uncouple yeast mitochondria
25. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12
26. Hyperexcitability to sulphonylurea in MODY3
27. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1 alpha gene mutations: Evidence for pharmacogenetics in diabetes
28. A genome-wide search for human noninsulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2
29. Loci on chromosome 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans
30. Genetic variations in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
31. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance
32. Role of calpain in adipocytes differentiation
33. The insulin-induced down-regulation of IRS-1 in 3T3-L1 adipocytes is mediated by a calcium-dependent thiol protease
34. Calpains play a role in insulin secretion and action
35. An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians
36. A genomewide scan for loci predisposing to type 2 diabetes in a UK population (the Diabetes UK Warren 2 repository): Analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q
37. Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10 q in Mexican Americans
38. Mapping of a gene for NIDDM associated with an insulin secretion defect by a genome scan in Finnish families
39. Type 2 diabetes: Evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs
40. Genome-wide search for type 2 diabetes-susceptibility genes in French whites: Evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type chromosome 1q21-q24
41. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome
42. Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes
43. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity
44. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia
45. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
46. The adipocyte-secreted protein Acrp 30 enhances hepatic insulin action